Results 161 to 170 of about 3,368,775 (301)

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Interview with Ahmed Abdel Latif Al-Najjar

open access: yes
مقابلة مع أحد مستمعي لإذاعة صوت أمريكا وخريج جامعة الأزهر، أحمد عبد اللطيف النجار، يناقش فيها تحليلة لبرامج إذاعة صوت أمريكا.An interview with a Voice of America listener and Al-Azhar University graduate, Ahmed Abdel-Latif Al-Najjar, in which he ...
Voice of America, Egypt
core   +1 more source

Global bee bioregions mirror those of other taxa despite a uniquely bimodal latitudinal diversity gradient. [PDF]

open access: yesProc Natl Acad Sci U S A
Laborieux L   +5 more
europepmc   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Geological society of America. Bulletin.

open access: yes
Voortzetting van: Bulletin of the Geological Society of America [ISSN 1050 ...
Geological society of America
core  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Bibliographical society of America. Papers.

open access: yes
Voortgezet als: Papers of the Bibliographical society of AmericaVoortzetting van: Bibliographical society of America.
Bibliographical society of America
core  

Home - About - Disclaimer - Privacy